Recruiting
Asthma
RecruitingInvestigational
A study to evaluate the effects of KT-621 in adults with moderate to severe eosinophilic asthma
Investigational
- Disease:Asthma
- Substances:–
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
Find therapies in clinical trials near you – page 6
- recruiting
- 3 961
- countries
- 28
- conditions
- 2 103
3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today
637 trials match your criteria
Recruiting
Multiple sclerosis
RecruitingInvestigationalNo placebo
A study to compare the effectiveness and safety of subcutaneous frexalimab versus intravenous frexalimab in adults with multiple sclerosis
InvestigationalNo placebo
- Disease:Multiple sclerosis
- Substances:Frexalimab
Countries:Belgium
Belgium- Participants:18–64 years
- Substances:Frexalimab
Recruiting
Juvenile idiopathic arthritis
RecruitingRegistered drugNo placebo
A study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis
Registered drugNo placebo
- Disease:Juvenile idiopathic arthritis
- Substances:Filgotinib
Countries:Belgium
Belgium- Participants:0–17 years
- Substances:Filgotinib
Recruiting
Acute lymphocytic leukaemia
RecruitingRegistered drugNo placebo
Study of Blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia
Registered drugNo placebo
- Disease:Acute lymphocytic leukaemia
- Substances:AsparaginaseBlinatumomab+13
Countries:Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Asparaginase
Recruiting
Endometrial cancer+2
RecruitingRegistered drugNo placebo
A study comparing Rinatabart Sesutecan to other treatments in patients with endometrial cancer who have previously received platinum-based chemotherapy and PD-L1 therapy
Registered drugNo placebo
- Disease:Endometrial cancerEndometrial cancer recurrent+1
- Substances:PaclitaxelDoxorubicin Hydrochloride+1
Countries:Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Paclitaxel
Recruiting
Colorectal cancer metastatic
RecruitingRegistered drugNo placebo
A study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer
Registered drugNo placebo
- Disease:Colorectal cancer metastatic
- Substances:BevacizumabCalcium Folinate+4
Countries:Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Bevacizumab
Recruiting
Interstitial lung disease+1
RecruitingInvestigational
A study to evaluate the effectiveness of BI 1015550 in people with lung abnormalities and a family history of pulmonary fibrosis
Investigational
- Disease:Interstitial lung diseasePulmonary fibrosis
- Substances:Bi 10155501-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
Countries:Belgium
Belgium- Participants:18–64 years · 65+ years · Healthy volunteers
- Substances:Bi 1015550
Recruiting
Chronic kidney disease+1
RecruitingInvestigational
A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
Investigational
- Disease:Chronic kidney diseaseArteriosclerosis
- Substances:–
Countries:Belgium
Belgium- Participants:18–64 years · 65+ years
Recruiting
Breast cancer metastatic
RecruitingRegistered drug
A study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer
Registered drug
- Disease:Breast cancer metastatic
- Substances:LetrozoleOp-1250+2
Countries:Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Letrozole
- Disease:Metabolic dysfunction-associated liver disease
- Substances:Ly3437943 SodiumTirzepatide
Countries:Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Ly3437943 Sodium
Recruiting
Squamous cell carcinoma of the hypopharynx+1
RecruitingRegistered drugNo placebo
Evaluation of Lymphocyte-Sparing Radiotherapy and All-Trans Retinoic Acid in Lateralized Oropharyngeal, Laryngeal, and Hypopharyngeal Squamous Cell Carcinoma
Registered drugNo placebo
- Disease:Squamous cell carcinoma of the hypopharynxLaryngeal squamous cell carcinoma
- Substances:CetuximabCisplatin+1
Countries:Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Cetuximab
Recruiting
Breast cancer metastatic
RecruitingRegistered drugNo placebo
Phase 1b-2 Study of Elacestrant and Abemaciclib in Patients with Brain Metastases from ER-Positive, HER2-Negative Breast Cancer
Registered drugNo placebo
- Disease:Breast cancer metastatic
- Substances:AbemaciclibElacestrant
Countries:Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Abemaciclib